Figure 2
From: Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
Body weight and IPGTT in control and linagliptin-treated mice. Comparison of the change in body weight (A) and IPGTT (B) in the control group (n =14) and the linagliptin-treated group (n =14). Data are mean ± SEM.
